With COVID-19 weakening her body, Hannah Jones, 24, was at risk of a heart attack. She was placed on a ventilator so she could breathe. It was very possible she…
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been…
Norton Healthcare Foundation announced that it received a $125,000 grant from the PNC Foundation to assist it in supporting COVID-19 relief efforts in the community. The funds will be used…
Norton Healthcare specialists are researching a variety of experimental therapies as possible treatments for patients with COVID-19. These therapies fall into four categories: Agents that work to prevent the virus…
Physicians around the country are testing a possible treatment for COVID-19 using plasma taken from blood donated by fully recovered COVID-19 patients, called convalescent plasma. Locally, Norton Healthcare began offering…
A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm…
Norton Healthcare physicians are testing a possible treatment for COVID-19 using convalescent plasma taken from blood donated by fully recovered COVID-19 patients. With approval from the U.S. Food and Drug…
When Brenda Montgomery enrolled in a clinical trial at Norton Cancer Institute in February 2016, she hoped the new drug being researched would trounce the cancer she had battled for…
The U.S. Food and Drug Administration recently approved a new cancer drug that has been available only to patients enrolled by a Norton Cancer Institute physician and one other researcher…